CN119997937A - 含有灭菌的杂环亚基乙酰胺衍生物的悬浮液 - Google Patents

含有灭菌的杂环亚基乙酰胺衍生物的悬浮液 Download PDF

Info

Publication number
CN119997937A
CN119997937A CN202380069446.7A CN202380069446A CN119997937A CN 119997937 A CN119997937 A CN 119997937A CN 202380069446 A CN202380069446 A CN 202380069446A CN 119997937 A CN119997937 A CN 119997937A
Authority
CN
China
Prior art keywords
aqueous suspension
suspension formulation
acetamide
ylidene
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380069446.7A
Other languages
English (en)
Chinese (zh)
Inventor
山下有希
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Mochida Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Mochida Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of CN119997937A publication Critical patent/CN119997937A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202380069446.7A 2022-09-29 2023-09-28 含有灭菌的杂环亚基乙酰胺衍生物的悬浮液 Pending CN119997937A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-156060 2022-09-29
JP2022156060 2022-09-29
PCT/JP2023/035547 WO2024071348A1 (ja) 2022-09-29 2023-09-28 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液

Publications (1)

Publication Number Publication Date
CN119997937A true CN119997937A (zh) 2025-05-13

Family

ID=90478164

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380069446.7A Pending CN119997937A (zh) 2022-09-29 2023-09-28 含有灭菌的杂环亚基乙酰胺衍生物的悬浮液

Country Status (7)

Country Link
EP (1) EP4595959A1 (https=)
JP (2) JP7589393B2 (https=)
KR (1) KR20250065723A (https=)
CN (1) CN119997937A (https=)
AU (1) AU2023352012A1 (https=)
MX (1) MX2025003326A (https=)
WO (1) WO2024071348A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025206172A1 (ja) * 2024-03-28 2025-10-02 千寿製薬株式会社 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ565080A (en) 2005-07-22 2011-03-31 Mochida Pharm Co Ltd Novel heterocyclidene acetamide derivative
JP6230743B1 (ja) 2017-05-31 2017-11-15 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の結晶
CN112409191A (zh) 2019-08-23 2021-02-26 持田制药株式会社 光学活性的氨基醇的制备方法
PL4019485T3 (pl) 2019-08-23 2024-10-21 Mochida Pharmaceutical Co., Ltd. Sposób wytwarzania pochodnych heterocyklidenoacetamidu
WO2021039023A1 (ja) 2019-08-23 2021-03-04 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の製造方法
MY207759A (en) 2019-10-04 2025-03-17 Mochida Pharm Co Ltd Pharmaceutical drug containing heterocyclidene acetamide derivative
JP7663009B2 (ja) 2021-03-31 2025-04-16 ニデックパワートレインシステムズ株式会社 回転電機、およびポンプ

Also Published As

Publication number Publication date
MX2025003326A (es) 2025-05-02
AU2023352012A1 (en) 2025-04-03
KR20250065723A (ko) 2025-05-13
JPWO2024071348A1 (https=) 2024-04-04
JP7589393B2 (ja) 2024-11-25
JP2025024083A (ja) 2025-02-19
WO2024071348A1 (ja) 2024-04-04
EP4595959A1 (en) 2025-08-06

Similar Documents

Publication Publication Date Title
RU2705376C2 (ru) Композиции пролекарства арипипразола
JP7026609B2 (ja) 微細粒子含有組成物およびその製法
JP7273235B2 (ja) ヘテロシクリデンアセトアミド誘導体含有懸濁液
CN119997937A (zh) 含有灭菌的杂环亚基乙酰胺衍生物的悬浮液
US10463674B2 (en) Process for manufacturing sterile ophthalmic pharmaceutical suspensions
CA3268119A1 (en) Sterilized heterocyclidene-acetamide-derivative-containing suspension
JP6850371B2 (ja) デゾシン類似体エステルを含む徐放懸濁液およびその製造方法
CN103228283A (zh) 含有二氟泼尼酯和托普霉素的水包油型乳状液组合物
JP7589394B2 (ja) ヘテロシクリデンアセトアミド誘導体を含む配合剤
JP6826167B2 (ja) アリピプラゾールプロドラッグ組成物
WO2025206172A1 (ja) 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物
US9820991B2 (en) Pharmaceutical composition comprising brinzolamide
WO2021199076A1 (en) Injectable aripiprazole formulation
WO2023148763A1 (en) Injectable pharmaceutical compositions of azole antifungal agents
WO2025125509A1 (en) Chemotherapeutic agent and compositions
HK40049829B (zh) 阿立哌唑前体药物组合物
WO2022195382A1 (en) A stable ophthalmic nanosupension of brinzolamide
HK40049829A (en) Aripiprazole prodrug compositions

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination